Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
Risk of cardiovascular (CV) disease is increased among RA patients. High inflammatory
burden associated with RA appears to be a key driver of the increased cardiovascular risk …
burden associated with RA appears to be a key driver of the increased cardiovascular risk …
Cardiovascular disease in autoimmune rheumatic diseases
I Hollan, PL Meroni, JM Ahearn, JWC Tervaert… - Autoimmunity …, 2013 - Elsevier
Various autoimmune rheumatic diseases (ARDs), including rheumatoid arthritis,
spondyloarthritis, vasculitis and systemic lupus erythematosus, are associated with …
spondyloarthritis, vasculitis and systemic lupus erythematosus, are associated with …
The interplay between inflammation and metabolism in rheumatoid arthritis
MS Chimenti, P Triggianese, P Conigliaro… - Cell death & …, 2015 - nature.com
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by extensive
synovitis resulting in erosions of articular cartilage and marginal bone that lead to joint …
synovitis resulting in erosions of articular cartilage and marginal bone that lead to joint …
Adipose tissue dysfunction in nascent metabolic syndrome
AA Bremer, I Jialal - Journal of obesity, 2013 - Wiley Online Library
The metabolic syndrome (MetS) confers an increased risk for both type 2 diabetes mellitus
(T2DM) and cardiovascular disease (CVD). Moreover, studies on adipose tissue biology in …
(T2DM) and cardiovascular disease (CVD). Moreover, studies on adipose tissue biology in …
Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
Aims To identify distinct temporal likelihoods of age-related comorbidity (ARC) diagnoses:
cardiovascular diseases (CVD), cancer, depression, dementia, and frailty-related diseases …
cardiovascular diseases (CVD), cancer, depression, dementia, and frailty-related diseases …
Jean-Charles Preiser
E Gremese, G Ferraccioli - medicine, 2013 - thelancet.com
Tofacitinib for rheumatoid arthritis Page 1 Correspondence 1812 www.thelancet.com Vol 381
May 25, 2013 same chance of getting results as those with BMI <30, since BMI can affect the …
May 25, 2013 same chance of getting results as those with BMI <30, since BMI can affect the …
Busting the myth of methotrexate chronic hepatotoxicity
V Di Martino, DW Verhoeven, F Verhoeven… - Nature Reviews …, 2023 - nature.com
Methotrexate is a key component of the treatment of inflammatory rheumatic diseases and
the mainstay of therapy in rheumatoid arthritis. Hepatotoxicity has long been a concern for …
the mainstay of therapy in rheumatoid arthritis. Hepatotoxicity has long been a concern for …
[HTML][HTML] Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers
R López-Mejías, S Castañeda… - Autoimmunity …, 2016 - Elsevier
Cardiovascular disease (CV) is the most common cause of premature mortality in patients
with rheumatoid arthritis (RA). This is the result of an accelerated atherosclerotic process …
with rheumatoid arthritis (RA). This is the result of an accelerated atherosclerotic process …
Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome
Context: Adipose tissue dysregulation causing aberrant adipokine secretion contributes
toward the proinflammatory state of metabolic syndrome (MetS). However, there are scant …
toward the proinflammatory state of metabolic syndrome (MetS). However, there are scant …
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)
The growing body of evidence recognizing the adipose tissue (AT) as an active endocrine
organ secreting bioactive mediators involved in metabolic and inflammatory disorders …
organ secreting bioactive mediators involved in metabolic and inflammatory disorders …